CMIC conducts all aspects of clinical trial procedures in Japan on behalf of overseas clients, from the initial application for a clinical trial to reporting of side effects.
The appointment of ICCC is obligated by Good Clinical Practice in Japan if a sponsor (who does not have domicile in Japan) want to conduct clinical trial in Japan.
ICCC acts as same as pharmaceutical company to conduct clinical trials in Japan.
- CMIC has built a network of the latest knowledge and wide-ranging information by accepting a broad range of business from various clients.
- Supported by its experience, CMIC provides the complete range of services required for drug development and customizes them for each product concept.
- Procedure of the application for approval to a foreign manufacturer's MHLW, various notifications, documents presentation, etc.
- Offer the information to the importer of drugs who imports the approved items.
- Offer of Japanese information to a foreign manufacturer
- Management of clinical trials
